Adaptive Biotechnologies
Adaptive Biotechnologies Corp. is a biotechnology company based in Seattle, Washington, that focuses on immune-driven medicine. Founded in 2009, the company specializes in decoding the genetics of the adaptive immune system to develop clinical products for diagnosing, treating, and monitoring diseases such as cancer, autoimmune disorders, and infectious diseases. The company’s proprietary immune-sequencing platform provides insights into T-cell and B-cell receptors, enabling the development of various products and services. Key offerings include immunoSEQ, which sequences immune receptors; clonoSEQ, a clinical assay for detecting minimal residual disease; T-Detect, a diagnostic tool for identifying diseases; and services for vaccine development and T-cell receptor screening. Adaptive collaborates with pharmaceutical companies, research institutions, and healthcare providers to advance personalized medicine and improve patient care.
Work at Adaptive Biotechnologies in HR or recruiting? Claim this page
Headcount trend
Adaptive Biotechnologies went from 591 employees in Oct 2024 to 641 in Sep 2026. Apr to Sep 2026: 16 people joined, 11 left.
Org structure
Headcount by department
Salaries at Adaptive Biotechnologies
All salaries2 salary profiles in the US
H-1B sponsorship
The department split adds up all the years listed above. FY2025 alone: 3 filings.
Peer reviews
Worked with someone at Adaptive Biotechnologies?
Anonymous peer reviews on OffTheRecord
Hiring now
Similar companies
Adaptive Biotechnologies FAQ
How many employees does Adaptive Biotechnologies have?
Adaptive Biotechnologies has about 641 employees, up 0.9% over the 3 months to Sep 2026.
Does Adaptive Biotechnologies sponsor H1B visas?
Yes. Adaptive Biotechnologies filed 3 H1B (LCA) applications in FY2025, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Adaptive Biotechnologies's revenue per employee?
Adaptive Biotechnologies makes about $279K in revenue per employee, based on $178.96M annual revenue and 641 employees.
How much does Adaptive Biotechnologies pay?
6figr has 2 salary profiles for Adaptive Biotechnologies in the US, with pay broken down by role, level, gender and ethnicity on the Adaptive Biotechnologies salaries page. See Adaptive Biotechnologies salaries
Is Adaptive Biotechnologies a public company?
Yes. Adaptive Biotechnologies is publicly traded under the ticker ADPT on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.
